招股书显示，健康之路2021年、2022年、2023年营收分别为4.3亿元、5.69亿元、12.44亿元；毛利分别为1.73亿元、2.46亿元、4亿元。该公司2024年上半年营收为6.11亿元，同比增长14%；运营利润为247.5万元，同比下降88%；期内亏损为5727.5万元，上年同期的期内亏损为1.05亿元。On the second day of its listing, Health Road (02587) surged over 8%, reaching a high of 11.64 Hong Kong dollars, nearly a 50% increase from the offering price of 7.8 Hong Kong dollars. As of the time of writing, it has risen by 7.5%, trading at 11.46 Hong Kong dollars, with a transaction volume of 4.6757 million Hong Kong dollars, and its total market value once exceeded 10 billion Hong Kong dollars.
According to the Zhitong Finance APP, Health Road (02587) surged more than 8% on its second day of listing, reaching a high of 11.64 HKD, an increase of nearly 50% compared to the offering price of 7.8 HKD. As of the time of this report, it is up 7.5%, priced at 11.46 HKD, with a transaction volume of 4.6757 million HKD and a total market value that briefly surpassed 10 billion HKD.
Health Road operates a digital health medical services platform in China. According to Frost & Sullivan data, based on the number of registered individual users on the platform as of December 31, 2023, the company is the fourth largest digital health medical services platform. Based on 2023 revenue, Health Road is the fifth largest digital health medical services platform, with a market share of less than 5%.
The prospectus shows that Health Road's revenues in 2021, 2022, and 2023 were 0.43 billion yuan, 0.569 billion yuan, and 1.244 billion yuan, respectively; gross profits were 0.173 billion yuan, 0.246 billion yuan, and 0.4 billion yuan, respectively. The company's revenue for the first half of 2024 was 0.611 billion yuan, a year-on-year increase of 14%; operating profit was 2.475 million yuan, a year-on-year decrease of 88%; during this period, the loss was 57.275 million yuan, compared to a loss of 0.105 billion yuan in the same period last year.
